RxDoctor Payments Data

Dwone Marshall-Brown, NP

Family · Baton Rouge, LANPI 1164791802

Payments from drug & device makers

$599in general payments, 2019–2025

Across 20 payments — averaging $29.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$289
  • AbbVie$90
  • Otsuka America Pharmaceutical, Inc.$65
  • Lilly USA, LLC$44
  • Novartis$32
  • GSK$20
  • plus $60 from 4 others

What the payments were for

  • Food & beverage$599100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$599 in reported general payments places this provider in the 50th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana

Medicare billing

Part B allowed, 2024
$61,964
Medicare patients
128
Services billed
838

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide81$93,371
JardianceEmpagliflozin74$48,071
LinzessLinaclotide64$43,455
OzempicSemaglutide23$29,924
TrulicityDulaglutide27$27,025
EliquisApixaban29$18,780
FarxigaDapagliflozin Propanediol20$10,815
Breo ElliptaFluticasone/Vilanterol11$4,542
Sucralfate13$2,354
Albuterol Sulfate HfaAlbuterol Sulfate68$2,315
Atorvastatin Calcium323$2,309
Doxepin Hcl20$1,884
Duloxetine Hcl24$1,668
Potassium Chloride124$1,628
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$1,613

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$44$120,396108 claims
AbbVieLinzess$90$43,45564 claims
Novo NordiskOzempic$14$29,92423 claims
GSKBreo Ellipta$20$4,54211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,610 family providers in Louisiana.

Other family in Baton Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →